Oramed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ORMP Oramed Pharmaceuticals Inc
GOTU Gaotu Techedu Inc
SGDVV Safe & Green Development Corp
GLBZ Glen Burnie Bancorp
PHAR Pharming Group NV
CARD Max Auto Industry -3X Inverse Leveraged ETN
HIW Highwoods Properties Inc
HFRO Highland Opportunities and Income Fund
HDV iShares Core High Dividend ETF
HDELY Heidelberg Materials AG
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Oramed Pharmaceuticals Inc. is a pharmaceutical company, which is engaged in the research and development of pharmaceutical solutions with its technology platform. Its POD (Protein Oral Delivery) technology has been designed to protect orally delivered proteins from detrimental enzymatic activity within the gastrointestinal tract and to enhance their absorption across the intestinal wall. Its pipeline includes ORMD-0801 diabetes, ORMD-0901, and ORMD-0801 non-alcoholic steatohepatitis (NASH). Its flagship product, ORMD-0801, allows insulin to travel from the gastrointestinal tract via the portal vein to the liver. It is conducting Phase III trials in patients with type 2 diabetes. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone, that stimulates the secretion of insulin from the pancreas. It is also engaged in the research and development of an oral vaccine for COVID-19 through its subsidiary, Oravax Medical Inc.

Premarket

Last Trade
Delayed
$2.78
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.15 (5.70%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.63
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
9,431

10-day average volume:
154,644
9,431
Historical quotes & splits

Ocugen Inc. Stock Falls Thursday, Underperforms Market

5:16 pm ET May 11, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) slid 6.13% to $0.70 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.17% to 4,130.62 and Dow Jones Industrial Average falling 0.66% to 33,309.51.

The stock's fall snapped a four-day winning streak.

Ocugen Inc. closed $2.41 below its 52-week high ($3.11), which the company achieved on July 8th.

Trading volume (5.7 M) remained 733,563 below its 50-day average volume of 6.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 11, 2023 17:16 ET (21:16 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure